Alexandra Barratt

Aug 14, 2024 | bmj.com | Jonathan E. Slutzman |Alexandra Barratt |Jodi D. Sherman

Jonathan E Slutzman, assistant professor of emergency medicine1, Alexandra Barratt, professor of public health2, Jodi D Sherman, associate professor of anesthesiology3 1Center for the Environment and Health Massachusetts General Hospital Harvard Medical School 2Wiser Healthcare University of Sydney 3Yale Center on Climate Change and Health Yale School of Public Health Corrrespondence to: J Sherman jodi.sherman{at}yale.edu New concordat is necessary but no match for the scale of the challenge...

Dec 18, 2023 | thelancet.com | Scott McAlister |Alexandra Barratt |Katy JL Bell |Forbes McGain

1Mattila TJ Use of input–output analysis in LCA. in: Hauschild MZ Rosenbaum RK Olsen SI Life Cycle Assessment; theory and practice. Springer International Publishing, New York City, NY: 349-372 Knowing both the direct emissions of each sector, and the indirect emissions from a sector's purchases, a CODifferent methods to quantify the carbon impact of health care produce different answers.

Oct 11, 2023 | onlinelibrary.wiley.com | Michael Caruana |Roman Gulati |Ruth Etzioni |Alexandra Barratt

ABS Australian Bureau of Statistics CI confidence interval ERSPC European Randomised Study of Screening for Prostate Cancer NSW New South Wales NSWCR New South Wales Cancer Registry PCFA Prostate Cancer Foundation of Australia PLCO Prostate, Lung, Colorectal and Ovarian screening trial PSA prostate specific antigen 1 INTRODUCTION Prostate cancer is the most commonly diagnosed cancer in Australian men and their second most common cause of cancer death.1 An estimated 19 508 new cases and 3306...

Sep 14, 2023 | paperity.org | Brooke Nickel |Kirsten J McCaffery |Jesse Jansen |Alexandra Barratt

PLOS ONE, Jul 2023 Management of low-risk ductal carcinoma in situ (DCIS) is controversial, with clinical trials currently assessing the safety of active monitoring amidst concern about overtreatment. Little is known about general community views regarding DCIS and its management. We aimed to explore women’s understanding and views about low-risk DCIS and current and potential future management options.

Jul 21, 2023 | journals.plos.org | Brooke Nickel |Kirsten J McCaffery |Jesse Jansen |Alexandra Barratt

Loading metrics Open Access Peer-reviewedResearch Article AbstractManagement of low-risk ductal carcinoma in situ (DCIS) is controversial, with clinical trials currently assessing the safety of active monitoring amidst concern about overtreatment. Little is known about general community views regarding DCIS and its management. We aimed to explore women’s understanding and views about low-risk DCIS and current and potential future management options.